Panome Bio转发了
How does obesity impact immunotherapy? The answer lies in metabolomics and proteomics. Obesity-driven metabolic changes can influence tumor progression, immune response, and checkpoint inhibitor efficacy, yet these factors are often overlooked in preclinical studies. Join TD2 Oncology and Panome Bio for an in-depth discussion on how Diet-Induced Obese (DIO) models enhance immunotherapy predictions and shape the future of drug development. ?? April 10, 2025 | ?? 11:30 AM – 1:00 PM ?? Residence Inn Boston Cambridge Featured Speakers: ?? Erin Trachet, Sr. Director, Scientific Engagement, TD2 Oncology ?? Tiffany Bernardo, Business Development Manager, Panome Bio Seats are limited—register now to secure your spot! https://hubs.ly/Q03bxQ960